title: Treatment of respiratory disease
text: Singh B, Sadiq H, Noguchi A and Keenan W. (2002). Efficacy of albuterol inhalation in treatment
  of hyperkalemia in premature neonates. The Journal of Pediatrics, 141(1), pp.16-20.
  2. Greenough A, Emery E, Brooker R and Gamsu H (1992). Salbutamol infusion to treat neonatal
  hyperkalaemia. Journal of Perinatal Medicine, 20(6), pp.437-441.
  3. Murdoch I, Dos Anjos R and Haycock G. (1991). Treatment of hyperkalaemia with intravenous
  salbutamol. Archives of Disease in Childhood, 66(4), pp.527-528.
  4. Kemper M, Harps E, Hellwege H and Müller-Wiefel D. (1996). Effective treatment of acute
  hyperkalaemia in childhood by short-term infusion of salbutamol. European Journal of
  Pediatrics, 155(6), pp.495-497.
  5. Moresco L, Bruschettini M, Cohen A, Gaiero A, Calevo MG. Salbutamol for transient tachypnea
  of the newborn. Cochrane Database Syst Rev. 2016.
  6. Ng G, da Silva O, Ohlsson A. Bronchodilators for the prevention and treatment of chronic lung
  disease in preterm infants. Cochrane Database Syst Rev. 2016.
  7. Kirpalani H, Doren G, Schmidt B, Tan Y, Santos R, Soldin S. (1990). Respiratory response and
  pharmacokinetics of intravenous salbutamol in infants with bronchopulmonary dysplasia.
  Critical Care Medicine, 18(12), pp. 1374-1377.
  8. Mandelberg A, Krupnik Z, Houri S, Smetana S, Gilad E, Matas Z, Priel IE. Salbutamol metered-
  dose inhaler with spacer for hyperkalemia: how fast? How safe?. CHEST Journal. 1999 Mar
  1;115(3):617-22
  9. Yaseen H, Khalaf M, Dana A, Yaseen N, Darwich M. Salbutamol versus cation-exchange resin
  (kayexalate) for the treatment of nonoliguric hyperkalemia in preterm infants. American journal, f perinatology. 2008 Feb;25(03):193-7.
  |